Xeris appoints Nerissa Kreher to board; CEO John Shannon named Chair

Xeris Biopharma Holdings, Inc.

Dr. Nerissa Kreher appointed to board effective July 1, 2026, expanding board to eight members.
CEO John Shannon named Chair of the Board effective July 1, 2026.
Marla Persky transitions to Lead Independent Director.
Dr. Kreher is CMO of Alltrna and has over 20 years of rare disease experience.
Dr. Kreher received initial equity award of ~$450,000 in options and RSUs.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.